trial

Implementation of Digital CBT for Insomnia in First Episode Psychosis

NCTId NCT05050201
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 22 (estimated)
Sponsored by NHS Greater Glasgow and Clyde
Primary completion 2022-04-20
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
22 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2021-04-20
Primary completion
2022-04-20
Eligibility
ALL · 16 Years · 35 Years

Interventions & indications

Drugs
Sleepio

Sponsors

NHS Greater Glasgow and ClydeLead Sponsor
University of GlasgowCollaborator
Big Health Inc.Collaborator

Investigators

1
Andrew Gumley, PhDPrincipal Investigator

Sites

2 total
Glasgow, United KingdomGlasgow, United Kingdom

Facts & assertions

4 sourced
Enrollment
22
Phase
NA
Primary Completion Date
2022-04-20
Status
UNKNOWN
relationships
The graph out of here
drug
Sleepio
drug
lead_sponsor
NHS Greater Glasgow and Clyde
company
collaborator
University of Glasgow
company
Big Health Inc.
company
indication
Sleep Initiation and Maintenance Disorders
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Andrew Gumley, PhD
person